SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-037878
Filing Date
2024-04-30
Accepted
2024-04-30 16:31:15
Documents
123
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0204570-20f_enlivex.htm   iXBRL 20-F 2075592
2 AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF THE COMPANY ea020457001ex1-1_enlivex.htm EX-1.1 137730
3 DESCRIPTION OF ORDINARY SHARES ea020457001ex2-1_enlivex.htm EX-2.1 38846
4 AGREEMENT, DATED AS OF MARCH 31, 2024, BY AND BETWEEN ENLIVEX THERAPEUTICS R&D L ea020457001ex4-18_enlivex.htm EX-4.18 63060
5 SUBSIDIARIES OF ENLIVEX THERAPEUTICS LTD ea020457001ex8-1_enlivex.htm EX-8.1 2883
6 CERTIFICATION ea020457001ex12-1_enlivex.htm EX-12.1 9383
7 CERTIFICATION ea020457001ex12-2_enlivex.htm EX-12.2 9392
8 CERTIFICATION ea020457001ex13-1_enlivex.htm EX-13.1 3261
9 CERTIFICATION ea020457001ex13-2_enlivex.htm EX-13.2 3239
10 CONSENT OF YAREL + PARTNERS ea020457001ex15-1_enlivex.htm EX-15.1 3744
11 ENLIVEX THERAPEUTICS LTD. EXECUTIVE OFFICER CLAWBACK POLICY ea020457001ex97-1_enlivex.htm EX-97.1 65632
12 GRAPHIC image_001.jpg GRAPHIC 17197
13 GRAPHIC image_002.jpg GRAPHIC 5235
14 GRAPHIC image_003.jpg GRAPHIC 4338
15 GRAPHIC image_004.jpg GRAPHIC 58861
16 GRAPHIC image_005.jpg GRAPHIC 55871
17 GRAPHIC image_006.jpg GRAPHIC 74549
18 GRAPHIC image_007.jpg GRAPHIC 21422
19 GRAPHIC image_008.jpg GRAPHIC 24418
20 GRAPHIC image_009.jpg GRAPHIC 18774
21 GRAPHIC image_010.jpg GRAPHIC 17555
22 GRAPHIC image_011.jpg GRAPHIC 21593
23 GRAPHIC fin_001.jpg GRAPHIC 5652
24 GRAPHIC fin_002.jpg GRAPHIC 31350
25 GRAPHIC image_012.jpg GRAPHIC 4021
26 GRAPHIC image_013.jpg GRAPHIC 6053
27 GRAPHIC image_014.jpg GRAPHIC 5686
  Complete submission text file 0001213900-24-037878.txt   9198459

Data Files

Seq Description Document Type Size
28 XBRL SCHEMA FILE enlv-20231231.xsd EX-101.SCH 86261
29 XBRL CALCULATION FILE enlv-20231231_cal.xml EX-101.CAL 62239
30 XBRL DEFINITION FILE enlv-20231231_def.xml EX-101.DEF 322193
31 XBRL LABEL FILE enlv-20231231_lab.xml EX-101.LAB 637058
32 XBRL PRESENTATION FILE enlv-20231231_pre.xml EX-101.PRE 337516
127 EXTRACTED XBRL INSTANCE DOCUMENT ea0204570-20f_enlivex_htm.xml XML 888401
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36578 | Film No.: 24897800
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)